期刊文献+

盆腔炎性疾病后遗症患者外周血miR-34a、SIRT1的表达及临床意义 被引量:7

Expressions and clinical significance of miR-34a and SIRT1 in peripheral blood of patients with chronic pelvic inflammatory disease
下载PDF
导出
摘要 目的探究盆腔炎性疾病后遗症患者外周血微小RNA-34a(miR-34a)、沉默信息调节因子1(SIRT1)的表达及临床意义。方法回顾性选取2017年8月至2019年11月河北中石油中心医院收治的136例盆腔炎性疾病后遗症患者为观察组,同期140例体检健康的妇女为对照组。实时荧光定量PCR(qRT-PCR)法检测血清miR-34a、SIRT1水平;酶联免疫吸附试验法检测两组血清白细胞介素4(IL-4)、白细胞介素1β(IL-1β)及肿瘤坏死因子-α(TNF-α)水平;Pearson法分析患者血清miR-34a、SIRT1水平间及与血清IL-4、IL-1β、TNF-α水平的相关性;多因素Logistic回归分析影响盆腔炎性疾病后遗症发生的因素。结果观察组患者血清miR-34a、IL-1β、TNF-α水平为1.42±0.33、(139.17±44.15)pg/mL、(79.52±25.24)pg/mL,显著高于对照组[1.01±0.22、(77.86±21.54)pg/mL、(46.61±13.79)pg/mL],SIRT1、IL-4水平为(33.26±8.53)pg/mL、0.69±0.18,显著低于对照组[(48.68±13.22)pg/mL、1.03±0.23],差异均有统计学意义(P<0.05)。血清miR-34a、IL-1β、TNF-α水平为影响盆腔炎性疾病后遗症发生的危险因素(P<0.05),血清SIRT1、IL-4水平为影响盆腔炎性疾病后遗症发生的保护因素(P<0.05)。盆腔炎性疾病后遗症患者血清miR-34a水平与IL-4水平呈显著负相关(r=-0.518,P<0.05),与IL-1β、TNF-α水平均呈显著正相关(r=0.459、0.564,P<0.05);血清SIRT1水平与IL-4水平呈正相关(r=0.462,P<0.05),与IL-1β、TNF-α水平呈负相关(r=-0.541、-0.550,P<0.05);血清miR-34a水平与SIRT1水平呈显著负相关(r=-0.538,P<0.05)。结论盆腔炎性疾病后遗症患者血清miR-34a水平升高,SIRT1水平降低,二者均与炎症因子水平密切相关,可能通过影响炎症反应共同参与盆腔炎性疾病后遗症发生,可为盆腔炎性疾病后遗症防治过程中炎症反应的调控提供一定参考。 Objective To investigate the expressions and clinical significance of microRNA-34a(miR-34a)and SIRT1 in peripheral blood of patients with chronic pelvic inflammation.Methods A total of 136 patients with chronic pelvic inflammatory disease who admitted to Hebei Petrochina Central Hospital were retrospectively selected as the observation group from August 2017 to November 2019,and 140 healthy women were selected as the control group.The levels of serum miR-34a and SIRT1 were detected by real-time fluorescent quantitative PCR(qRT-PCR);the levels of serum interleukin-4(IL-4),interleukin-1β(IL-1β)and tumor necrosis factor-α(TNF-α)were detected by enzyme-linked immunosorbent assay(ELISA);Pearson's method was used to analyze the correlations between serum miR-34a,SIRT1 levels and serum IL-4,IL-1βlevels,the correlation between serum TNF-αlevel and SIRT1;and multivariate Logistic regression was used to analyze the factors affecting the occurrence of chronic pelvic inflammation.Results The serum levels of miR-34a,IL-1βand TNF-αin the observation group were 1.42±0.33,(139.17±44.15)pg/mL,(79.52±25.24)pg/mL,which were significantly higher than those in the control group[1.01±0.22,(77.86±21.54)pg/mL,(46.61±13.79)pg/mL],the levels of SIRT1,IL-4 were(33.26±8.53)pg/mL,0.69±0.18,which were significantly lower than those in the control group[(48.68±13.22)pg/mL,1.03±0.23],the differences were statistically significant(P<0.05).The levels of serum miR-34a,IL-1β,TNF-αwere the risk factors of chronic pelvic inflammation(P<0.05),and the levels of serum SIRT1 and IL-4 were the protective factors(P<0.05).The level of serum miR-34a in patients with chronic pelvic inflammation was negatively correlated with the level of IL-4(r=-0.518,P<0.05),and positively correlated with the levels of IL-1βand TNF-α(r=0.459,0.564;P<0.05);the level of serum SIRT1 was positively correlated with IL-4(r=0.462,P<0.05),and negatively correlated with IL-1β,TNF-α(r=-0.541,-0.550;P<0.05);and there was a significant negative correlation between serum miR-34a and SIRT1(r=-0.538,P<0.05).Conclusion The level of serum miR-34a in patients with chronic pelvic inflammation is increased,the level of SIRT1 is decreased,and both of them are closely related to the level of inflammatory factors.They may participate in the occurrence of chronic pelvic inflammation by influencing the inflammatory response,which can provide some reference for the regulation of inflammatory response in the process of prevention and treatment of chronic pelvic inflammation.
作者 霍志平 李红霞 王宏利 孟宪宁 HUO Zhi-ping;LI Hong-xia;WANG Hong-li(Department of Gynecology,Hebei Petrochina Central Hospital,Langfang Hebei 065000,China)
出处 《临床和实验医学杂志》 2022年第5期525-529,共5页 Journal of Clinical and Experimental Medicine
基金 河北省科技计划项目(编号:180200176)。
关键词 盆腔炎性疾病后遗症 外周血 微小RNA-34a 沉默信息调节因子1 Chronic pelvic inflammatory disease Peripheral blood MicroRNA-34a Silent information regulator 1
  • 相关文献

参考文献11

二级参考文献98

  • 1李任,仇丽鸿.牙髓卟啉单胞菌内毒素致病性研究进展[J].中国实用口腔科杂志,2009,2(12):756-758. 被引量:22
  • 2Jennifer Raisch,Arlette Darfeuille-Michaud,Hang Thi Thu Nguyen.Role of microRNAs in the immune system,inflammation and cancer[J].World Journal of Gastroenterology,2013,19(20):2985-2996. 被引量:18
  • 3童舜华,石富娟.慢性盆腔炎的分期论治浅析[J].中医药学刊,2004,22(7):1290-1291. 被引量:11
  • 4丰有吉,沈铿主编.妇产科学[M].2版.北京:人民卫生出版社,2011:214.215.
  • 5Ehses JA,Ellingsgaard H,Boni-Schnetzler M,et al. Pancreatic is-let inflammation in type 2 diabetes : from alpha and beta cell com-pensation to dysfunction. Arch Physiol Biochem, 2009,11:240-247.
  • 6Richardson SJ, Willcox A,Bone AJ,et al. Islet-associated macro-phages in type 2 diabetes. Diabetologia,2009,5 : 1686-1688.
  • 7Ehses JA,Lacraz G,Giroix MH,et al. IL-1 antagonism reduces hy-perglycemia and tissue inflammation in the type 2 diabetic GK rat.Proc Natl Acad Sci U S A,2009,106: 13998-14003.
  • 8Lacraz G, Giroix MH, Kassis N , et al. Islet endothelial activationand oxidative stress gene expression is reduced by IL-IRa treat-ment in the type 2 diabetic GK rat. PLoS One, 2009,4 : e6963.
  • 9Giroix MH, Irminger JC, Lacraz G, et al. Hypercholesterolaemia,signs of islet microangiopathy and altered angiogenesis precede on-set of type 2 diabetes in the Goto-Kakizaki ( GK ) rat.Diabetologia,2011,54:2451-2462.
  • 10Milne JC,Lambert PD,Schenk S,et al. Small molecule activatorsof SIRT1 as therapeutics for the treatment of type 2 diabetes.Nature,2007,450:712-716.

共引文献467

同被引文献84

引证文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部